ALB and cancer: For instance, Abraxane, the paclitaxel-HSA nanoformulation with an average particle size of 130 nm, which was prepared through high-pressure homogenization technology, has already been approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of cancer [94,95].